{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CagA oncoprotein", "Helicobacter pylori", "In silico analyses", "Medicinal plants", "Phenolic compounds", "Prospective analysis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38835850", "DateRevised": {"Year": "2024", "Month": "06", "Day": "07"}, "Article": {"Language": ["eng"], "ELocationID": ["10.5306/wjco.v15.i5.653"], "ArticleDate": [], "Journal": {"ISSN": "2218-4333", "JournalIssue": {"Volume": "15", "Issue": "5", "PubDate": {"Year": "2024", "Month": "May", "Day": "24"}}, "Title": "World journal of clinical oncology", "ISOAbbreviation": "World J Clin Oncol"}, "ArticleTitle": "<i>In silico</i> prospective analysis of the medicinal plants activity on the CagA oncoprotein from <i>Helicobacter pylori</i>.", "Pagination": {"StartPage": "653", "EndPage": "663", "MedlinePgn": "653-663"}, "Abstract": {"AbstractText": ["Colonization with <i>Helicobacter pylori</i> (<i>H. pylori</i>) has a strong correlation with gastric cancer, and the virulence factor CagA is implicated in carcinogenesis. Studies have been conducted using medicinal plants with the aim of eliminating the pathogen; however, the possibility of blocking <i>H. pylori</i>-induced cell differentiation to prevent the onset and/or progression of tumors has not been addressed. This type of study is expensive and time-consuming, requiring <i>in vitro</i> and/or <i>in vivo</i> tests, which can be solved using bioinformatics. Therefore, prospective computational analyses were conducted to assess the feasibility of interaction between phenolic compounds from medicinal plants and the CagA oncoprotein.", "To perform a computational prospecting of the interactions between phenolic compounds from medicinal plants and the CagA oncoprotein of <i>H. pylori</i>.", "In this <i>in silico</i> study, the structures of the phenolic compounds (ligands) kaempferol, myricetin, quercetin, ponciretin (flavonoids), and chlorogenic acid (phenolic acid) were selected from the PubChem database. These phenolic compounds were chosen based on previous studies that suggested medicinal plants as non-drug treatments to eliminate <i>H. pylori</i> infection. The three-dimensional structure model of the CagA oncoprotein of <i>H. pylori</i> (receptor) was obtained through molecular modeling using computational tools from the I-Tasser platform, employing the threading methodology. The primary sequence of CagA was sourced from GenBank (BAK52797.1). A screening was conducted to identify binding sites in the structure of the CagA oncoprotein that could potentially interact with the ligands, utilizing the GRaSP online platform. Both the ligands and receptor were prepared for molecular docking using AutoDock Tools 4 (ADT) software, and the simulations were carried out using a combination of ADT and AutoDock Vina v.1.2.0 software. Two sets of simulations were performed: One involving the central region of CagA with phenolic compounds, and another involving the carboxy-terminus region of CagA with phenolic compounds. The receptor-ligand complexes were then analyzed using PyMol and BIOVIA Discovery Studio software.", "The structure model obtained for the CagA oncoprotein exhibited high quality (C-score = 0.09) and was validated using parameters from the MolProbity platform. The GRaSP online platform identified 24 residues (phenylalanine and leucine) as potential binding sites on the CagA oncoprotein. Molecular docking simulations were conducted with the three-dimensional model of the CagA oncoprotein. No complexes were observed in the simulations between the carboxy-terminus region of CagA and the phenolic compounds; however, all phenolic compounds interacted with the central region of the oncoprotein. Phenolic compounds and CagA exhibited significant affinity energy (-7.9 to -9.1 kcal/mol): CagA/kaempferol formed 28 chemical bonds, CagA/myricetin formed 18 chemical bonds, CagA/quercetin formed 16 chemical bonds, CagA/ponciretin formed 13 chemical bonds, and CagA/chlorogenic acid formed 17 chemical bonds. Although none of the phenolic compounds directly bound to the amino acid residues of the K-Xn-R-X-R membrane binding motif, all of them bound to residues, mostly positively or negatively charged, located near this region.", "<i>In silico</i>, the tested phenolic compounds formed stable complexes with CagA. Therefore, they could be tested <i>in vitro</i> and/or <i>in vivo</i> to validate the findings, and to assess interference in CagA/cellular target interactions and in the oncogenic differentiation of gastric cells."], "CopyrightInformation": "\u00a9The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidade Federal do Paran\u00e1, Campus Toledo, Toledo 85919-899, Brazil."}], "LastName": "Vieira", "ForeName": "Rafaela Viana", "Initials": "RV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidade Tecnol\u00f3gica Federal do Paran\u00e1, Campus Toledo, Paran\u00e1 85902-490, Brazil."}], "LastName": "Peiter", "ForeName": "Gabrielle Caroline", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidade Federal da Bahia, Instituto Multidisciplinar em Sa\u00fade-Campus An\u00edsio Teixeira, Vit\u00f3ria da Conquista 45029-094, Brazil."}], "LastName": "de Melo", "ForeName": "Fabr\u00edcio Freire", "Initials": "FF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidade Federal do Paran\u00e1, Campus Toledo, Toledo 85919-899, Brazil."}, {"Identifier": [], "Affiliation": "Universidade Federal do Paran\u00e1-Setor Palotina, Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia, Palotina 85950-000, Brazil."}], "LastName": "Zarpelon-Schutz", "ForeName": "Ana Carla", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidade Federal do Paran\u00e1, Campus Toledo, Toledo 85919-899, Brazil."}, {"Identifier": [], "Affiliation": "Universidade Federal do Paran\u00e1-Setor Palotina, Programa de P\u00f3s-gradua\u00e7\u00e3o em Biotecnologia, Palotina 85950-000, Brazil. kadimateixeira@ufpr.br."}], "LastName": "Teixeira", "ForeName": "K\u00e1dima Nayara", "Initials": "KN"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "World J Clin Oncol", "NlmUniqueID": "101549149", "ISSNLinking": "2218-4333"}, "CoiStatement": "Conflict-of-interest statement: We have no financial relationships to disclose."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kamboj AK, Cotter TG, Oxentenko AS. Helicobacter pylori: The Past, Present, and Future in Management. Mayo Clin Proc. 2017;92:599\u2013604.", "ArticleIdList": ["28209367"]}, {"Citation": "Fera MT, Giannone M, Pallio S, Tortora A, Blandino G, Carbone M. Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains. Int J Antimicrob Agents. 2001;17:151\u2013154.", "ArticleIdList": ["11165121"]}, {"Citation": "Boyanova L. Comparative evaluation of two methods for testing metronidazole susceptibility of Helicobacter pylori in routine practice. Diagn Microbiol Infect Dis. 1999;35:33\u201336.", "ArticleIdList": ["10529879"]}, {"Citation": "Park JB, Imamura L, Kobashi K. Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole. Biol Pharm Bull. 1996;19:182\u2013187.", "ArticleIdList": ["8850302"]}, {"Citation": "Midolo PD, Norton A, von Itzstein M, Lambert JR. Novel bismuth compounds have in vitro activity against Helicobacter pylori. FEMS Microbiol Lett. 1997;157:229\u2013232.", "ArticleIdList": ["9435101"]}, {"Citation": "Sorba G, Bertinaria M, Di Stilo A, Gasco A, Scaltrito MM, Brenciaglia MI, Dubini F. Anti-Helicobacter pylori agents endowed with H2-antagonist properties. Bioorg Med Chem Lett. 2001;11:403\u2013406.", "ArticleIdList": ["11212121"]}, {"Citation": "Lamont JT.  Treatment regimens for Helicobacter pylori in adults. [cited May 20, 2023]. Available from: https://www.uptodate.com/contents/treatment-regimens-for-helicobacter-pylori-in-adults?search=Helicobacter%20pylori&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H2609998802 ."}, {"Citation": "Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of Antibiotic Resistance in Helicobacter pylori: A\u00a0Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018;155:1372\u20131382.e17.", "ArticleIdList": ["PMC6905086", "29990487"]}, {"Citation": "Sathianarayanan S, Ammanath AV, Biswas R, B A, Sukumaran S, Venkidasamy B. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb Pathog. 2022;168:105594.", "ArticleIdList": ["35605740"]}, {"Citation": "Dinat S, Orchard A, Van Vuuren S. A scoping review of African natural products against gastric ulcers and Helicobacter pylori. J Ethnopharmacol. 2023;301:115698.", "ArticleIdList": ["36174808"]}, {"Citation": "Wang YC. Medicinal plant activity on Helicobacter pylori related diseases. World J Gastroenterol. 2014;20:10368\u201310382.", "ArticleIdList": ["PMC4130844", "25132753"]}, {"Citation": "Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138:2099\u20132107.", "ArticleIdList": ["PMC3601579", "23497863"]}, {"Citation": "Singh RP, Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal. 2002;4:655\u2013663.", "ArticleIdList": ["12230878"]}, {"Citation": "Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, Mabry TJ. Flavonoid effects relevant to cancer. J Nutr. 2002;132:3482S\u20133489S.", "ArticleIdList": ["12421874"]}, {"Citation": "Chan FL, Choi HL, Chen ZY, Chan PS, Huang Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett. 2000;160:219\u2013228.", "ArticleIdList": ["11053652"]}, {"Citation": "Kuo SM. Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit Rev Oncog. 1997;8:47\u201369.", "ArticleIdList": ["9516086"]}, {"Citation": "Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26:1001\u20131043.", "ArticleIdList": ["19636448"]}, {"Citation": "Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M. Important Flavonoids and Their Role as a Therapeutic Agent. Molecules. 2020;25", "ArticleIdList": ["PMC7697716", "33187049"]}, {"Citation": "Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42:e2020004.", "ArticleIdList": ["PMC7056944", "32023777"]}, {"Citation": "Oliveira AKS, Silva LLL, Miguel MP, Blanco AJV, Carneiro LC, Barbosa MS. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION? Arq Gastroenterol. 2021;58:468\u2013475.", "ArticleIdList": ["34909852"]}, {"Citation": "Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:196\u2013219.", "ArticleIdList": ["PMC5489429", "28413197"]}, {"Citation": "Backert S, Tegtmeyer N, Fischer W. Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015;10:955\u2013965.", "ArticleIdList": ["PMC4493163", "26059619"]}, {"Citation": "Nesi\u0107 D, Miller MC, Quinkert ZT, Stein M, Chait BT, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol. 2010;17:130\u2013132.", "ArticleIdList": ["PMC3006182", "19966800"]}, {"Citation": "Rahman MM, Rahaman MS, Islam MR, Rahman F, Mithi FM, Alqahtani T, Almikhlafi MA, Alghamdi SQ, Alruwaili AS, Hossain MS, Ahmed M, Das R, Emran TB, Uddin MS. Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects. Molecules. 2021;27", "ArticleIdList": ["PMC8746501", "35011465"]}, {"Citation": "Zheng W, Zhang C, Li Y, Pearce R, Bell EW, Zhang Y. Folding non-homologous proteins by coupling deep-learning contact maps with I-TASSER assembly simulations. Cell Rep Methods. 2021;1", "ArticleIdList": ["PMC8336924", "34355210"]}, {"Citation": "Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, Jain S, Lewis SM, Arendall WB 3rd, Snoeyink J, Adams PD, Lovell SC, Richardson JS, Richardson DC. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293\u2013315.", "ArticleIdList": ["PMC5734394", "29067766"]}, {"Citation": "Santana CA, Silveira SA, Moraes JPA, Izidoro SC, de Melo-Minardi RC, Ribeiro AJM, Tyzack JD, Borkakoti N, Thornton JM. GRaSP: a graph-based residue neighborhood strategy to\u00a0predict binding sites. Bioinformatics. 2020;36:i726\u2013i734.", "ArticleIdList": ["33381849"]}, {"Citation": "Vieira MN, Winterhalter P, Jerz G. Flavonoids from the flowers of Impatiens glandulifera Royle isolated by high performance countercurrent chromatography. Phytochem Anal. 2016;27:116\u2013125.", "ArticleIdList": ["26751603"]}, {"Citation": "Guti\u00e9rrez-Rebolledo GA, Gardu\u00f1o-Siciliano L, Garc\u00eda-Rodr\u00edguez RV, P\u00e9rez-Gonz\u00e1lez MZ, Ch\u00e1vez MI, Bah M, Siordia-Reyes GA, Chamorro-Cevallos GA, Jim\u00e9nez-Arellanes MA. Anti-inflammatory and toxicological evaluation of Moussonia deppeana (Schldl. & Cham) Hanst and Verbascoside as a main active metabolite. J Ethnopharmacol. 2016;187:269\u2013280.", "ArticleIdList": ["27125592"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u20132791.", "ArticleIdList": ["PMC2760638", "19399780"]}, {"Citation": "Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol. 1996;6:402\u2013406.", "ArticleIdList": ["8804827"]}, {"Citation": "Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model. 2021;61:3891\u20133898.", "ArticleIdList": ["PMC10683950", "34278794"]}, {"Citation": "Pantsar T, Poso A. Binding Affinity via Docking: Fact and Fiction. Molecules. 2018;23", "ArticleIdList": ["PMC6222344", "30061498"]}, {"Citation": "Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999;112:531\u2013552.", "ArticleIdList": ["10027275"]}, {"Citation": "Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111\u20132115.", "ArticleIdList": ["7743510"]}, {"Citation": "Saito A, Alvi S, Valant C, Christopoulos A, Carbone SE, Poole DP. Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders. Br J Pharmacol. 2022", "ArticleIdList": ["36565295"]}, {"Citation": "Paduch R, Kandefer-Szersze\u0144 M, Trytek M, Fiedurek J. Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 2007;55:315\u2013327.", "ArticleIdList": ["18219762"]}, {"Citation": "Meoti FC.  An\u00e1lise dos mecanismos de a\u00e7\u00e3o antinociceptiva e antinflamat\u00f3ria do flavon\u00f3ide miricetina: estudos in vivo e in vitro. UFSM 2006. Available from: https://repositorio.ufsm.br/handle/1/4391 ."}, {"Citation": "Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003;417:12\u201317.", "ArticleIdList": ["12921774"]}, {"Citation": "Castillo-Ju\u00e1rez I, Gonz\u00e1lez V, Jaime-Aguilar H, Mart\u00ednez G, Linares E, Bye R, Romero I. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J Ethnopharmacol. 2009;122:402\u2013405.", "ArticleIdList": ["19162157"]}, {"Citation": "Szewczyk K, Zidorn C, Biernasiuk A, Komsta \u0141, Granica S. Polyphenols from Impatiens (Balsaminaceae) and their antioxidant and antimicrobial activities. Ind Crops Prod. 2016;86:262\u2013272."}, {"Citation": "Youssef FS, Altyar AE, Omar AM, Ashour ML. Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential. Front Pharmacol. 2021;12:619373.", "ArticleIdList": ["PMC8072666", "33912041"]}, {"Citation": "Elhady SS, Youssef FS, Alahdal AM, Almasri DM, Ashour ML. Anti-Hyperglycaemic Evaluation of Buddleia indica Leaves Using In Vitro, In Vivo and In Silico Studies and Its Correlation with the Major Phytoconstituents. Plants (Basel) 2021;10", "ArticleIdList": ["PMC8617869", "34834714"]}, {"Citation": "Jang HG, Heo BG, Park YS, Namiesnik J, Barasch D, Katrich E, Vearasilp K, Trakhtenberg S, Gorinstein S. Chemical composition, antioxidant and anticancer effects of the seeds and leaves of indigo (Polygonum tinctorium Ait.) plant. Appl Biochem Biotechnol. 2012;167:1986\u20132004.", "ArticleIdList": ["22644642"]}, {"Citation": "Kataoka M, Hirata K, Kunikata T, Ushio S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol. 2001;36:5\u20139.", "ArticleIdList": ["11211212"]}, {"Citation": "da Silva LP, Pereira E, Pires TCSP, Alves MJ, Pereira OR, Barros L, Ferreira ICFR. Rubus ulmifolius Schott fruits: A detailed study of its nutritional, chemical and bioactive properties. Food Res Int. 2019;119:34\u201343.", "ArticleIdList": ["30884664"]}, {"Citation": "Martini S, D'Addario C, Colacevich A, Focardi S, Borghini F, Santucci A, Figura N, Rossi C. Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents. 2009;34:50\u201359.", "ArticleIdList": ["19386474"]}, {"Citation": "Bae EA, Han MJ, Kim DH. In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites. Planta Med. 1999;65:442\u2013443.", "ArticleIdList": ["10454900"]}, {"Citation": "Kim MJ, Kim BG, Ahn JH. Biosynthesis of bioactive O-methylated flavonoids in Escherichia coli. Appl Microbiol Biotechnol. 2013;97:7195\u20137204.", "ArticleIdList": ["23771780"]}, {"Citation": "Kang GD, Kim DH. Ponciretin attenuates ethanol-induced gastric damage in mice by inhibiting inflammatory responses. Int Immunopharmacol. 2017;43:179\u2013186.", "ArticleIdList": ["28013186"]}, {"Citation": "Eftekhari M, Shams Ardekani MR, Amin M, Mansourian M, Saeedi M, Akbarzadeh T, Khanavi M. Anti-Helicobacter pylori Compounds from Oliveria decumbens Vent. through Urease Inhibitory In-vitro and In-silico Studies. Iran J Pharm Res. 2021;20:476\u2013489.", "ArticleIdList": ["PMC8653682", "34904002"]}, {"Citation": "Tran Trung H, Truong Thi Huynh H, Nguyen Thi Thuy L, Nguyen Van Minh H, Thi Nguyen MN, Luong Thi MN. Growth-Inhibiting, Bactericidal, Antibiofilm, and Urease Inhibitory Activities of Hibiscus rosa sinensis L. Flower Constituents toward Antibiotic Sensitive- and Resistant-Strains of Helicobacter pylori. ACS Omega. 2020;5:20080\u201320089.", "ArticleIdList": ["PMC7439261", "32832762"]}, {"Citation": "Mej\u00eda JJ, Sierra LJ, Ceballos JG, Mart\u00ednez JR, Stashenko EE. Color, Antioxidant Capacity and Flavonoid Composition in Hibiscus rosa-sinensis Cultivars. Molecules. 2023;28", "ArticleIdList": ["PMC9960340", "36838766"]}, {"Citation": "Stein M, Rappuoli R, Covacci A. The cag Pathogenicity Island. In: Helicobacter pylori: Physiology and Genetics. :2001."}, {"Citation": "Verli H.  Bioinform\u00e1tica: da biologia \u00e0 flexibilidade molecular. 2014; 1-12 Available from: https://lume.ufrgs.br/bitstream/handle/10183/166105/001012172.pdf?sequence=1&isAllowed=y ."}, {"Citation": "Gonz\u00e1lez A, Salillas S, Vel\u00e1zquez-Campoy A, Espinosa Angarica V, Fillat MF, Sancho J, Lanas \u00c1. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Sci Rep. 2019;9:11294.", "ArticleIdList": ["PMC6683298", "31383920"]}, {"Citation": "Tegtmeyer N, Backert S. Role of Abl and Src family kinases in actin-cytoskeletal rearrangements induced by the Helicobacter pylori CagA protein. Eur J Cell Biol. 2011;90:880\u2013890.", "ArticleIdList": ["21247656"]}, {"Citation": "Bess\u00e8de E, M\u00e9graud F. Microbiota and gastric cancer. Semin Cancer Biol. 2022;86:11\u201317.", "ArticleIdList": ["35533800"]}, {"Citation": "Tohidpour A. CagA-mediated pathogenesis of Helicobacter pylori. Microb Pathog. 2016;93:44\u201355.", "ArticleIdList": ["26796299"]}, {"Citation": "Fidler R, Sokolov AV, Verbitski\u012d MSh, Papazov IP. [Monoclonal antibodies against the beta subunit of human chorionic gonadotropin] Biull Eksp Biol Med. 1988;106:693\u2013695.", "ArticleIdList": ["2462933"]}, {"Citation": "Chang CC, Kuo WS, Chen YC, Perng CL, Lin HJ, Ou YH. Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori. PLoS One. 2016;11:e0150061.", "ArticleIdList": ["PMC4775065", "26934189"]}, {"Citation": "Nelson DL. Princ\u00edpios de bioqu\u00edmica de Lehninger. 6ed. 2014; 115-151."}]}], "History": [{"Year": "2023", "Month": "12", "Day": "15"}, {"Year": "2024", "Month": "4", "Day": "1"}, {"Year": "2024", "Month": "4", "Day": "18"}, {"Year": "2024", "Month": "6", "Day": "5", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "5", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "5", "Hour": "3", "Minute": "50"}, {"Year": "2024", "Month": "5", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38835850", "PMC11145963", "10.5306/wjco.v15.i5.653"]}}]}